Hunan Fangsheng Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Hunan Fangsheng Pharmaceutical has a total shareholder equity of CN¥1.6B and total debt of CN¥695.7M, which brings its debt-to-equity ratio to 44.5%. Its total assets and total liabilities are CN¥3.1B and CN¥1.5B respectively. Hunan Fangsheng Pharmaceutical's EBIT is CN¥187.4M making its interest coverage ratio 6. It has cash and short-term investments of CN¥215.5M.
Key information
44.5%
Debt to equity ratio
CN¥695.65m
Debt
Interest coverage ratio | 6x |
Cash | CN¥215.50m |
Equity | CN¥1.56b |
Total liabilities | CN¥1.54b |
Total assets | CN¥3.10b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603998's short term assets (CN¥1.1B) do not cover its short term liabilities (CN¥1.1B).
Long Term Liabilities: 603998's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥394.2M).
Debt to Equity History and Analysis
Debt Level: 603998's net debt to equity ratio (30.7%) is considered satisfactory.
Reducing Debt: 603998's debt to equity ratio has increased from 17.2% to 44.5% over the past 5 years.
Debt Coverage: 603998's debt is well covered by operating cash flow (23.5%).
Interest Coverage: 603998's interest payments on its debt are well covered by EBIT (6x coverage).